Jacques Delaunay

6.3k total citations · 2 hit papers
123 papers, 3.2k citations indexed

About

Jacques Delaunay is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Jacques Delaunay has authored 123 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Hematology, 31 papers in Genetics and 23 papers in Molecular Biology. Recurrent topics in Jacques Delaunay's work include Acute Myeloid Leukemia Research (55 papers), Hematopoietic Stem Cell Transplantation (27 papers) and Acute Lymphoblastic Leukemia research (22 papers). Jacques Delaunay is often cited by papers focused on Acute Myeloid Leukemia Research (55 papers), Hematopoietic Stem Cell Transplantation (27 papers) and Acute Lymphoblastic Leukemia research (22 papers). Jacques Delaunay collaborates with scholars based in France, United States and United Kingdom. Jacques Delaunay's co-authors include Xavier Thomas, Christopher Arthur, Hagop M. Kantarjian, Grzegorz Mazur, Christian Récher, Agnieszka Wierzbowska, Farhad Ravandi, Mark D. Minden, Jiří Mayer and Jaroslav Čermák and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

In The Last Decade

Jacques Delaunay

118 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

2012 818 citations Hagop M. Kantarjian, Xavier Thomas et al. Journal of Clinical Oncology profile →
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials

2014 479 citations Robert K. Hills, Sylvie Castaigné et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacques Delaunay France	27	2.1k	1.1k	635	613	583	123	3.2k
Kumudha Balakrishnan United States	26	520 0.3×	1.2k 1.1×	484 0.8×	1.5k 2.5×	216 0.4×	52	2.8k
P. Koch Germany	23	621 0.3×	303 0.3×	905 1.4×	393 0.6×	795 1.4×	67	3.1k
Glenn Noronha United States	26	402 0.2×	1.3k 1.2×	319 0.5×	548 0.9×	99 0.2×	56	2.6k
Michaela Feuring‐Buske Germany	25	900 0.4×	1.1k 1.0×	499 0.8×	291 0.5×	205 0.4×	76	2.2k
Peter Liebisch Germany	29	963 0.5×	1.8k 1.6×	801 1.3×	216 0.4×	48 0.1×	61	3.0k
Thomas O’Hare United States	37	3.8k 1.8×	1.6k 1.5×	966 1.5×	2.9k 4.8×	554 1.0×	116	5.7k
Rajni Sinha United States	18	266 0.1×	574 0.5×	1.0k 1.6×	864 1.4×	114 0.2×	61	2.5k
Kuniaki Itoh Japan	23	156 0.1×	354 0.3×	866 1.4×	243 0.4×	149 0.3×	125	1.9k
Christian Dittrich Austria	33	170 0.1×	1.4k 1.3×	1.6k 2.6×	509 0.8×	56 0.1×	136	4.0k
M. Margarida Bernardo United States	27	485 0.2×	929 0.8×	1.3k 2.0×	80 0.1×	49 0.1×	34	2.6k

Countries citing papers authored by Jacques Delaunay

Since Specialization

Citations

This map shows the geographic impact of Jacques Delaunay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Delaunay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Delaunay more than expected).

Fields of papers citing papers by Jacques Delaunay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Delaunay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Delaunay. The network helps show where Jacques Delaunay may publish in the future.

Co-authorship network of co-authors of Jacques Delaunay

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Delaunay. A scholar is included among the top collaborators of Jacques Delaunay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Delaunay. Jacques Delaunay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bourgeois, Amandine Le, Pierre Péterlin, Thierry Guillaume, et al.. (2016). Higher Early Monocyte and Total Lymphocyte Counts Are Associated with Better Overall Survival after Standard Total Body Irradiation, Cyclophosphamide, and Fludarabine Reduced-Intensity Conditioning Double Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Adults. Biology of Blood and Marrow Transplantation. 22(8). 1473–1479. 8 indexed citations

Arthur, Christopher, Jaroslav Čermák, Jacques Delaunay, et al.. (2015). Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia. Journal of Blood Medicine. 6. 25–25. 3 indexed citations

Hills, Robert K., Sylvie Castaigné, Frederick R. Appelbaum, et al.. (2014). Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials. The Lancet Oncology. 15(9). 986–996. 479 indexed citations breakdown →

Péterlin, Pierre, Jacques Delaunay, Thierry Guillaume, et al.. (2014). Complete Donor T Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced-Intensity Conditioning Regimen Allogeneic Transplantation in Adults. Biology of Blood and Marrow Transplantation. 21(1). 180–184. 10 indexed citations

Thépot, Sylvain, Simone Boehrer, Thomas Prébet, et al.. (2014). A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure. Leukemia Research. 38(12). 1430–1434. 13 indexed citations

Bourgeois, Amandine Le, Myriam Labopin, Thierry Guillaume, et al.. (2014). Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults. Experimental Hematology. 42(11). 945–954. 11 indexed citations

Malard, Florent, Patrice Chevallier, Thierry Guillaume, et al.. (2014). Continuous Reduced Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Institution’s Three Decade Experience. Biology of Blood and Marrow Transplantation. 20(8). 1217–1223. 26 indexed citations

Imbert‐Marcille, Berthe‐Marie, Lucie Planche, Marie Rimbert, et al.. (2013). Prospective Comparison Of Five Viral Infections (HHV6, CMV, EBV, ADV, BKv) After Umbilical Cord Blood (UCB) Vs PBSC Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation (allo-SCT) In Adults. Blood. 122(21). 3284–3284. 1 indexed citations

Thomas, Xavier, et al.. (2013). A Post Hoc Sensitivity Analysis of Survival Probabilities in a Multinational Phase III Trial of Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 14(1). 68–72. 17 indexed citations

10.

Bourgeois, Amandine Le, Catherine Mohr, Thierry Guillaume, et al.. (2013). Comparison of Outcomes after Two Standards-of-Care Reduced-Intensity Conditioning Regimens and Two Different Graft Sources for Allogeneic Stem Cell Transplantation in Adults with Hematologic Diseases: A Single-Center Analysis. Biology of Blood and Marrow Transplantation. 19(6). 934–939. 16 indexed citations

11.

Kantarjian, Hagop M., Xavier Thomas, Anna Dmoszyńska, et al.. (2012). Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Journal of Clinical Oncology. 30(21). 2670–2677. 818 indexed citations breakdown →

12.

Chevallier, Patrice, Nelly Robillard, Aude Charbonnier, et al.. (2012). Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study. Blood. 119(11). 2474–2477. 11 indexed citations

13.

Malard, Florent, Richard Szydlo, Éolia Brissot, et al.. (2009). Impact of Cyclosporine-A Concentration on the Incidence of Severe Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 16(1). 28–34. 60 indexed citations

14.

Perrot, Aurore, Isabelle Luquet, Arnaud Pigneux, et al.. (2009). Prognostic Value of the ‘Monosomal Karyotype’ Entity in Elderly Patients with AML: a GOELAMS Study of 186 Patients with Unfavourable Cytogenetic Abnormalities.. Blood. 114(22). 1577–1577. 3 indexed citations

15.

Adès, Lionel, Simone Boehrer, Thomas Prébet, et al.. (2008). Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study. Blood. 113(17). 3947–3952. 107 indexed citations

16.

Chevallier, Patrice, Beatrice Mahé, Richard Garand, et al.. (2008). Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression. International Journal of Hematology. 88(2). 209–211. 9 indexed citations

17.

Chevallier, Patrice, Cyrille Touzeau, Sameh Ayari, et al.. (2007). Re-administration of a combination of chemotherapy+Gemtuzumab at relapse in CD33+ AML patient allows to second remission and is feasible without extra toxicity. Leukemia Research. 32(8). 1321–1322. 2 indexed citations

18.

Delaunay, Jacques, et al.. (2004). The Effect of Anti-CD44 Monoclonal Antibodies on Differentiation and Proliferation of Human Acute Myeloid Leukemia Cells. Leukemia & lymphoma. 45(8). 1501–1510. 47 indexed citations

19.

Jousselme, Bruno, Philippe Blanchard, N. Gallego-Planas, et al.. (2003). Photomechanical Control of the Electronic Properties of Linear π‐Conjugated Systems. Chemistry - A European Journal. 9(21). 5297–5306. 31 indexed citations

20.

Bernadou, Jean, et al.. (1995). SYNTHESIS AND CHARACTERIZATION OF A CATIONIC MANGANESE PORPHYRIN-BISBENZIMIDAZOLE DYE (HOECHST 33258) CONJUGATE AS A POTENTIAL SEQUENCE-SELECTIVE DN A CLEAVER. New Journal of Chemistry. 19. 873–876. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact